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Studies of the cell-specific processing of neuroendoctine peptides have shown that nemoendocrine cells occasionally fail to mature the biosynthetic 
precursors to bioactive peptides, or that they do so to a negligible xtent only. Instead, inactive precursors and processing intermediates accumulate 
in the cells. Thus, the expression of genes encoding hormonal peptides is in certain cells and under certain conditions attenuated at the posttransla- 
tional level. The exact molecular mechanisms of posttranslational tenuation are still largely unknown. The review emphasizes that postttranslation- 
al attenuation may play a significant role during normal cell differentiation and in the carcinogenic transformation of cells. The existence of post- 
translational attenuation has significant biological and clinical implications 
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1. INTRODUCTION 
It is a well-known fact that gene expression com- 
prises multiple steps from initiation of the transcription 
to the appearance of the encoded protein or peptide in 
its active, functional form. It is also common 
knowledge that although transcriptional control is of 
paramount significance, expression may in addition be 
controlled at steps following transcription. Thus, at- 
tenuation mechanisms have been described, which sup- 
press the expression of procaryotic and eucaryotic 
genes both at transcriptional and translational levels 
(for reviews, see [1,2]). 
Some proproteins and many neuroendocrine propep- 
tides undergo complex and highly elaborate post- 
translational processing [3,4]. Consequently, there are 
ample opportunities for control of the expression of 
neuropeptides and peptide hormones at several steps 
along the posttranslational pathways. Attenuation 
mechanisms might therefore operate also in the post- 
translational phase of expression in addition to the 
earlier described transcriptional and translational at- 
tenuations [1,2]. So far, however, the possibility of 
posttranslational attenuation has received little atten- 
tion, if any. 
During studies of the cell-specific processing of 
precursors for the neuroendocrine peptides, 
cholecystokinin (CCK) and gastrin, we have during re- 
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cent years observed a striking accumulation of precur- 
sors in certain cells almost devoid of smaller precursor 
fragments, whether bioactive or not [5,6]. These obser- 
vations suggest hat attenuation of gene expression oc- 
curs indeed also at the posttranslational evel. The 
following review describes examples of posttransla- 
tional attenuation in normal adult cells. Moreover, the 
significance of posttranslational attenuation of peptide 
genes during ontogenetic development and car- 
cinogenic transformation will also be discussed. Since 
the CCK and gastrin systems of peptides will be used 
for illustration, a description of the normal, unat- 
tenuated processing of proCCK and progastrin will 
first be presented. 
2. UNATTENUATED proCCK AND PROGASTRIN 
PROCESSING 
In adult mammals, by far most gastrin is synthesized 
in the antral G-cells, and by far most CCK in intestinal 
I-cells and cerebrocortical neurons. After cotransla- 
tional removal of the N-terminal signal peptides, 
proCCK and progastrin are subjected to extensive 
covalent trimming before the mature bioactive peptides 
are ready for release from the cells. The posttransla- 
tional modifications comprise proteolytic cleavage at 
several di- and monobasic processing sites, O- 
sulphations at several tyrosyl residues, serine 
phosphorylations, glutamic acid cyclizations and 
phenylalanine cr-carboxyamidation (for review, see 
t7-91). 
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PREPROCCK OR - GASTRIN have an unusually well-defined active-site, i.e. the C- 
terminal Trp-Met-Asp-Phe-NH2 sequence. Finally, the 
processing steps required for synthesis of peptides hav- 
ing this carboxyamidated tetrapeptide sequence are 
well-known (Fig. 1). In other words, expression of the 
CCK and gastrin genes is phenotypically defined with 
great precision, i.e. by synthesis and release of peptides 
having the Trp-Met-Asp-Phe-NH2 C-terminus. -Trp-Met-Asp-Phe-Gly-Arg-Arg-Ser- 
I 
t__!-_ trypsin - like 
endopeptidase 
-Trp-Met-Asp-Phe-Gly-Arg-(Arg) 
-Trp -Met-Asp-Phe-Gly 
4_ peptidylglycine cr-amidating 
t 
monooxygenase (PAY 
- Trp - Met -Asp - Phe - NH, _ active-site 
Fig. 1. Posttranslational maturation of proCCK and progastrin. The 
identical active-site of the propeptides is -Trp-Met-Asp-Phe-NHZ. 
Only fragments with this n-amidated C-terminus have biological 
activity. The maturation process exposing the active-site, i.e. the 
enzymes and cofactors required, is now well-known (see also [4,9]). 
The CCK and gastrin systems are particularly useful 
models for examination of the posttranslational phase 
of gene expression for three reasons. First, the trimm- 
ing of the precursors to bioactive mature peptides com- 
prises as mentioned a large number of common 
processing steps. Second, the final bioactive products 
ATTENUATION 
In the above-mentioned ‘main factories’, the 
gastrointestinal endocrine cells and the cerebral CCK- 
neurons, proCCK and progastrin are processed almost 
completely (2 98%) to bioactive carboxyamidated pep- 
tides [4,10]. This is truly unattenuated processing. 
3. ATTENUATED proCCK AND PROGASTRIN 
PROCESSING IN ADULT CELLS 
Attenuated posttranslational processing occurs in 
cells that translate a given mRNA, but subsequently fail 
to mature the translation product to a functionally 
useful protein or peptide. Such condition might also be 
called silent gene expression. 
Our first example of attenuated posttranslational 
processing was discovered in normal adult porcine cor- 
ticotrophs, which - as indicated by the name - produce 
ACTH and other fragments of proopiomelanocortin 
(POMC) in large quantities. The corticotrophs, 
however, also express ignificant amounts of progastrin 
and proCCK [5], but process only a negligible fraction 
to peptides having the carboxyamidated active-site 
[5,1 I]. The corticotrophs therefore release neither 
bioactive CCK nor gastrin peptides. Nevertheless cor- 
ticotrophs are abundantly equipped with enzymes for 
cleavage at dibasic processing sites and for cy- 
carboxyamidation [3]. In addition the pituitary and 
MATURATION INACTIVATION 
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Fig. 2. Three different courses of the posttranslational phase of gene expression: by attenuation there is either no processing of the propeptide 
or a partial processing to biosynthetic intermediates without significant maturation of proper bioactive peptides. Examples of posttranslational 
attenuation are the corticotrophic expression of progastrin [5] and the cardiac expression of proenkephalin A [25]. By maturution the propeptide 
is fully processed to release the bioactive peptide. Maturation, cell-specific or not, is the classical and well-elucidated posttranslational course of 
the expression of peptide genes. By inactivation the matured bioactive peptide loses its biological activity either by proteolytic fragmentation or 
by derivatization of the active-site like the pituitary N-acetylation of ,&endorphin [26-281. It is possible that some inactivation occurs in most 
peptide-producing cells. 
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gastrointestinal amidation enzymes appear to be almost 
identical structurally as well as functionally [12]. It is 
therefore surprising that corticotrophs fail to mature 
both progastrin and proCCK [5]. 
We do not yet know the explanation. Perhaps the 
substrate specificity of processing enzymes is so high 
that those used to process POMC have only little effect 
on proCCK and progastrin. Perhaps the processing 
sites on pituitary progastrin and proCCK are modified 
in a way that interferes with the maturation process. 
Perhaps the proCCK and progastrin concentrations in 
the corticotrophs are too low for the corticotrophic 
processing enzymes, although the progastrin concentra- 
tions in the pituitary and antral cells are the same. The 
pituitary gastrin mRNA is apparently identical with 
that of the antral mucosa [13]. Therefore, alternative 
splicing cannot explain the lack of posttranslational 
processing. So far there are no reasons to believe that 
unprocessed or partly processed pituitary progastrin 
and proCCK per se have any biological activity. Also 
ontogenetic studies have so far failed to provide 
evidence of a more comprehensive foetal or neonatal 
pituitary synthesis and processing of which the pro- 
gastrin and proCCK in the adult might be a reflection 
(unpublished studies). 
In contrast with the pituitary, the low level of pro- 
gastrin in the adult mammalian pancreas [6] reflects, 
however, an extensive foetal and neonatal synthesis of 
bioactive, carboxyamidated gastrins [6,14,15]. The 
foetal synthesis in the pancreas seems to serve local 
growth control [16]. As discussed later, the fact that the 
normal adult pancreas expresses progastrin - although 
at a low level - shows that the gastrin producing car- 
cinomas in the pancreas are not ectopic. 
Other examples of low-level synthesis of progastrin 
and proCCK with attenuated posttranslational process- 
ing have been found in bronchial endocrine cells [17] 
and cerebellar neurons (unpublished results). The dif- 
ferent posttranslational pathway during attenuation is 
schematized in Fig. 2. 
4. ATTENUATED PROCESSING IN FOETAL AND 
NEONATAL CELLS 
Posttranslational attenuation may occur in two op- 
posite directions during the ontogenic development. In 
the first situation, considerable amounts of propeptides 
may accumulate in foetoneonatal cerebral neurons and 
peripheral endocrine cells in which the enzymatic 
machinery necessary for the processing to bioactive 
peptides is not yet available [ 18,191. Then at a certain 
stage of development, for instance in rats, immediately 
before or at weaning, the processing machinery 
matures [18,19]. 
The other situation concerns bioactive peptides that 
act also as growth factors, which are required to 
regulate foetal growth. In the adult the local re- 
quirements for growth factors have apparently 
diminished to such a degree that the posttranslational 
maturation of peptide growth factors ceases, so that the 
peptide-producing cells are left with moderate amounts 
of propeptides [5,6]. Thus, the developmental expres- 
sion of bioactive peptide seems to be regulated not only 
at the transcriptional but also at the posttranslational 
level. 
5. ATTENUATED PROCESSING IN 
TUMOUR CELLS 
The phenomenon of posttranslational attenuation 
may turn out to have specific implications for the 
understanding of carcinogenetic mechanisms and for 
improvement of cancer diagnosis. First, closer analysis 
of tissues from which the so-called peptide-producing 
ectopic tumours are developed indicates that genes en- 
coding the peptides produced in the tumours are ex- 
pressed also in the corresponding normal cells. A 
modest level of expression and subsequent posttransla- 
tional attenuation, however, has silenced the 
phenotypic expression so that only inactive precursors 
are present in the normal cells (for review, see [20]). 
Consequently, several peptide-producing tumours can- 
not be considered ectopic. They are eutopic. But the 
eutopic synthesis is camouflaged by posttranslational 
attenuation. Second, the size of the synthesis and the 
efficiency of the posttranslational processing in 
peptide-producing transformed tumours display gross 
individual variations. Many carcinomas therefore syn- 
thesize substantial quantities of propeptides but fail to 
mature the propeptides to any significant extent. In 
clinical terms these tumours are therefore silent and less 
easily diagnosed. By so-called processing-independent 
immunoanalysis [21] it seems possible now to diagnose 
peptide-producing carcinomas irrespective of the 
degree of posttranslational attenuation [22]. Third, 
since many neuroendocrine peptides also are growth 
factors, as previously mentioned, it is likely that the 
peptides synthesized in carcinomas may stimulate the 
growth of the tumour by local autocrine secretion [23]. 
Thus, even low-level expression with attenuation may 
by local secretion play a significant role in tumour 
growth. It is therefore important to detect expression of 
peptide genes in tumour cells, also when the expression 
is attenuated posttranslationally. 
6. ATTENUATED PROCESSING OF 
PROPEPTIDES OTHER THAN proCCK 
AND PROGASTRIN 
So far only few laboratories have described findings 
that correspond to posttranslational attenuation as 
defined in this review. The paucity is probably due to 
analytical shortcomings, because only few laboratories 
have developed the complex precursors assay pro- 
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cedures of sufficient sensitivity and specificity. Precur- remains to be seen. It is possible that the phenomenon 
sor analysis generally requires libraries of monospecific mainly occurs in the biogenesis of proteins and peptides 
radioimmunoassays used in combination with ap- have complex, multistep posttranslational processing 
propriate enzymography and chromatography [21,24]. pathways. 
One valid example has been reported by Howells et 
al. [25], who in the rat heart in addition to high concen- 
trations of proenkephalin A mRNA found significant 
amounts of a precursor protein corresponding to pro- 
enkephalin A, but only traces of mature enkephalin 
peptides. The precursor-product ratio >30 [25] cor- 
responds to those of proCCK-CCK and progastrin- 
gastrin found in our laboratory [5,6,19]. 
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Posttranslational attenuation as defined in this 
review (Fig. 2) should not be confused with inactiva- 
tion or degradation of the matured peptide products. 
N-Acetylation of pituitary and cerebral ,&endorphin is 
an example of the latter [26-281. Although peptide in- 
activation or degradation may lead to the same result 
as the posttranslational attenuation, i.e. absence of 
physiologically active peptides, the mechanisms never- 
theless differ substantially. In order to understand how 
gene expression is controlled in normal as well as sick 
and especially in transformed cells a clear conception of 
posttranslational attenuation is necessary. 
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